文献速递胃肠动力与功能性疾病

肠易激综合征与全因及病因特异性死亡率的时变关联:NIH-AARP队列研究

The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2025-11-21

基于NIH-AARP队列132,697人数据,5,030人(3.8%)有IBS诊断,随访至2019年。多变量Cox模型显示,IBS与全因死亡率呈时变负关联:随访>2-5年时HR=0.75(95%CI 0.64-0.88),>17年时HR=0.92(95%CI 0.87-0.98),癌症和心血管死亡风险亦随时间衰减。

要点

  • IBS诊断与全因死亡率降低相关,但关联强度随随访时间延长而衰减。
  • 随访>2-5年全因死亡HR=0.75(95%CI 0.64-0.88),>17年HR=0.92(95%CI 0.87-0.98)。
  • IBS患者癌症和心血管死亡风险亦降低,同样呈时间依赖性衰减。

核心结论

  • IBS与全因、癌症和心血管疾病死亡率呈时间依赖性负关联,随访早期关联较强,后期减弱。
  • 短期随访中的强关联可能受个人健康倡导/医疗可及性等混杂因素影响。

研究设计与样本

  • NIH-AARP饮食与健康研究队列,纳入132,697名有可用数据的个体。
  • 1994-2008年通过Medicare索赔数据识别IBS诊断,随访至2019年通过国家死亡索引获取死亡结局。
  • 采用多变量Cox比例风险回归模型,按随访时间分区(>2-5、>5-8、>8-11、>11-14、>14-17、>17年)估计HR和95%CI,调整包括饮食习惯及个人健康倡导/医疗可及性代理变量在内的混杂因素。

主要发现

  • 5,030人(3.8%)有 prevalent IBS诊断。
  • 随访>2-5年,IBS患者全因死亡风险较无IBS者低25%(HR=0.75,95%CI 0.64-0.88,完全调整模型)。
  • 随访>17年,IBS患者全因死亡风险仅低8%(HR=0.92,95%CI 0.87-0.98)。
  • IBS诊断者癌症和心血管疾病死亡风险亦较低,且随时间衰减。

临床怎么用

  • 临床解读IBS患者死亡风险时需考虑随访时间,短期观察到的较低风险可能部分源于健康倡导/医疗可及性混杂。
  • 对IBS患者长期管理仍应关注癌症和心血管疾病风险,尽管队列显示负关联。

局限性

  • 短期随访中关联似乎受个人健康倡导/医疗可及性强烈混杂。
  • 需进一步研究探索较长随访后观察到的关联的影响因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Evidence on the association between irritable bowel syndrome (IBS) and mortality is conflicting. In this study, we estimated the association between IBS and all-cause and cause-specific mortality in the NIH-AARP Diet and Health Study. METHODS: IBS diagnoses between 1994 and 2008 were identified from Medicare claims data, and mortality outcomes through 2019 were obtained through linkage to the National Death Index. Using multivariable Cox proportional hazards regression models, we estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cause-specific mortality within partitioned follow-up time categories (>2-5, >5-8, >8-11, >11-14, >14-17, and >17 years) with adjustment for confounders, including habitual diet and proxies for personal health advocacy/healthcare access. RESULTS: Of 132,697 individuals with available data, 5,030 (3.8%) had a prevalent IBS diagnosis. During the earliest follow-up interval (>2-5 years), the risk of all-cause mortality among individuals with IBS was 25% lower compared with those without IBS (HR = 0.75, 95% CI: 0.64-0.88), in the fully adjusted model. The inverse association attenuated over time such that during the >17-year follow-up interval, individuals with IBS had only an 8% lower risk of all-cause mortality (HR = 0.92, 95% CI: 0.87-0.98). Individuals diagnosed with IBS also had a lower risk of cancer and cardiovascular disease mortality, which attenuated over time. DISCUSSION: We found time-dependent inverse associations between IBS and all-cause, cancer and cardiovascular disease mortality. Although this association seemed to be strongly confounded by personal health advocacy/healthcare access during very short follow-up, further research is needed to explore the factors contributing to these associations observed after longer follow-up.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gutiérrez-Torres DS, Li F, Liao LM, et al. The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study. Am J Gastroenterol. 2025. PMID: 41518229. doi:10.14309/ajg.0000000000003861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。